Barely Significant
← all excerpts

Lipid-Based Gliclazide Nanoparticles for Treatment of Diabetes: Formulation, Pharmacokinetics, Pharmacodynamics and Subacute Toxicity Study.

Int J Nanomedicine · 2020 · PMC7038779 · PMID 32110012

Europe PMCDOI
1
hedged sentence
0.0010
closest p · 0.0× alpha
0.0010
boldest claim

The sentences

highly significantp ≤ 0.001actually significant
Statistical analysis showed a highly significant ( p ≤ 0.001 ) increase in C max after the administration of GLZ loaded SLNs when compared to raw GLZ powder.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.